Report forecast the global artificial pancreas devices
system market to grow at a CAGR of 7.40% during the period 2016-2020.
Artificial organs are human-made bioartificial devices,
which are implanted or integrated into individuals to replace or support
natural organs. These include artificial heart, kidney, pancreas, and cochlear
implants. Biocompatible materials such as polymers (polyurethane, polysulfone,
and porous polypropylene), biologics, ceramics, and metals are used to develop
artificial organs. These organs are incorporated with different technologies
like sensors, biomaterials, and innovative delivery systems. Artificial organs
perform the function of the natural organ and help the patient to live a
quality life. In few cases, artificial organs are capable of eliminating the
need for organ transplantation altogether.
The report covers the present scenario and the growth
prospects of the global artificial pancreas devices system market for
2016-2020. To calculate the market size, the report considers the revenue
generated from sales of the different products.
The market is divided into the following segments based
on geography:
- Americas
- APAC
- EMEA
According to the report, one driver in the market is
increasing initiatives of research organizations fostering innovation in the
market. The inspiring initiatives of research organizations such as JDRF enable
the development of innovative products in the market. JDRF launched Artificial Pancreas
Project in 2006 to foster the development of an artificial pancreas to help
individuals with diabetes. Subsequently, JDRF collaborated with Medtronic in
2014 to develop a novel redundant sensor system, which is designed to boost the
accuracy and reliability of APDS. The research also focused on the development
of orthogonally redundant sensor system, which integrates an electrochemical
sensor along with an optical sensor to provide accurate glucose values.
Earlier, in June 2013, JDRF collaborated with BD for a three-year time period
to develop a single optimized device that will handle multiple functions and
avoid the need and complexities of dwelling catheters. Recently, the
researchers at Harvard University started a program to identify and develop an
effective treatment for type 1 diabetes. Subsequently, National Institutes of
Health awarded $12.5 million to Harvard University in 2016 to undertake the
field testing of two artificial pancreas algorithms. Such initiatives lead to
the development of novel products as well as upgradation of existing systems.
Further, the report states that one challenge in the market
is lack of smart control algorithms affecting the adoption rate of existing
APDS. Though there are important developments in sensor and pump technology,
the APDS is associated with the delays and inaccuracies in glucose sensing and
insulin delivery. Such type of issues occurs when there is a disturbance in the
routine system (such as uptake of meal), which triggers a rapid glucose rise that
is significantly faster than the time required for insulin absorption and
action. Thus, the vendors should focus on designing an APDS with smart sensors
that consider a relatively slow response, giving time for the delays to fade
before the next control action. In particular, to avoid hypoglycemia after a
meal, the vendors has to design a moderately aggressive controller. This has
driven the vendors to research on new control design, model predictive control
(MPC) algorithm, which is based on a prediction of glucose dynamics using a
model of the individual's metabolic system. According to clinical studies, this
design may be better for mitigation of time delays due to subcutaneous glucose
sensing and insulin infusion. However, such smart algorithms have limited
clinical evidence, and it may take few more years to develop an ideal
algorithm.
Global Artificial Pancreas Devices System Market
2016-2020, has been prepared based on an in-depth market analysis with
inputs from industry experts. The report covers the market landscape and its
growth prospects over the coming years. The report also includes a discussion
of the key vendors operating in this market.
key players in the global artificial pancreas devices system
market: Medtronic, Johnson & Johnson, Insulet, Tandem Diabetes Care, and
Roche.
Other Prominent Vendors in the market are: Beta Bionics,
Bigfoot Biomedical, Cellnovo, Dexcom, Dose Safety, DreaMed Diabetes, Inreda
Diabetic, and Type Zero Technologies.
Market driver
- Growing technological integration fueling the market growth.
- For a full, detailed list, view our report
Market challenge
- Lack of smart control algorithms affecting the adoption rate of existing APDS.
- For a full, detailed list, view our report
Market trend
- Growing demand for remote monitoring application.
- For a full, detailed list, view our report
Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
Spanning over 85 pages and 64 Exhibits “Global
Artificial Pancreas Devices System Market 2016 - 2020” report covers Executive
summary, Scope of the report, Market research methodology, Introduction, Market
landscape, An overview of pancreas and diabetes, Need for better systems in the
management of diabetes, Artificial pancreas device system, Initiatives for the
development of APDS, FDA’s role in fostering the development of APDS,
Reimbursement scenario, Key clinical trials, Market segmentation by categories,
Geographical segmentation, Market drivers, Impact of drivers, Market
challenges, Impact of drivers and challenges, Market trends, Vendor landscape,
Key vendor analysis, Appendix.
For
more information Visit at: http://mrr.cm/3RR
Related Reports;
Nurse Call System Market in the US 2016-2020 - Visit at - http://mrr.cm/3RD
Global HPV Testing Market 2016-2020 - Visit at - http://mrr.cm/3Rz
No comments:
Post a Comment
Note: only a member of this blog may post a comment.